SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
In March 2023, Novartis’ (Basel, Switzerland), shared its latest data concerning Zolgensma. The findings reveal sustained durability up to 7.5 years post-dosing, with a 100% achievement of all assessed milestones in children treated before the onset of spinal muscular...
Please enjoy this excerpt from our book, Biotech Primer One: The Science Driving Biopharma Explained. Written for the non-scientist, this book aims to enhance your comprehension of the foundational biology needed to understand today’s advanced therapies, such as gene...
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.
